Evaluation of tyrosinase expression in canine and equine melanocytic tumors

American Journal of Veterinary Research

Volumn 73, Issue 2, 2012, Pages 272-278

  Phillips, Jeffrey C ^a,c   Lembcke, Luis M ^a   Noltenius, Christina E ^a   Newman, Shelley J ^a   Blackford, James T ^a   Grosenbaugh, Deborah A ^b   Timothy Leard, A ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c LINCOLN MEMORIAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PARAFFIN; PROTEIN S 100; RIBOSOME RNA; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HISTOLOGY; HORSE; LYMPH NODE METASTASIS; MALE; MELANOMA; NONHUMAN; PIGMENTATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; SKIN TUMOR; UVEA MELANOMA;

ANIMALS; CANCER VACCINES; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HORSE DISEASES; HORSES; MELANOMA; MONOPHENOL MONOOXYGENASE; RNA, MESSENGER; VACCINES, DNA;

CANIS FAMILIARIS; EQUIDAE;

EID: 84856630066     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.2.272     Document Type: Article

References (29)

1. Wang N, Hebert D. Tyrosinase maturation through the mammalian secretory pathway: bringing color to life. Pigment Cell Res 2006;19:3-18.
2. Schraermeyer U, Kopitz J, Peters S, et al. Tyrosinase biosynthesis in adult mammalian retinal pigment epithelial cells. Exp Eye Res 2006;83:315-321.
3. Hayasaka S, Nakazawa M, Ishiguro S, et al. Presence of tyrosinase activity in human ciliary body. Jpn J Ophthalmol 1986;30:32-35.
4. Ferguson C, Kidson S. The regulation of tyrosinase gene transcription. Pigment Cell Res 1997;10:127-138.
5. Vourc'h-Jourdain M, Volteau C, Nguyen J, et al. Melanoma gene expression and clinical course. Arch Dermatol Res 2009;301:673-679.
6. Ferguson A, Nichols L, Zarling A, et al. Strategies and challenges in eliciting immunity to melanoma. Immunol Rev 2008;222:28-42.
7. Bergman P, McKnight J, Novosad A, et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogenic human tyrosinase: a phase I trial. Clin Cancer Res 2003;9:1284-1290.
8. Ramos-Vara JA, Beissenherz ME, Miller MA, et al. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol 2000;37:597-608.
9. Stell AJ, Dobson JM, Scase TJ, et al. Evaluation of variants of melanoma-associated antigen genes and mRNA transcripts in melanomas of dogs. Am J Vet Res 2009;70:1512-1520.
10. Seltenhammer M, Heere-Ress E, Brandt S, et al. Comparative histopathology of grey-horse-melanoma and human malignant melanoma. Pigment Cell Res 2004;17:674-681.
11. Rosengren G, Pielberg G, Golovko A, et al. A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nat Genet 2008;40:1004-1009.
12. Seliger B. Molecular mechanisms of MHC class I abnormalities and APM components in human tumors. Cancer Immunol Immunother 2008;57:1719-1726.
13. Garrido F, Algarra I, Garcia-Lora AM. The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible "hard" lesions. Cancer Immunol Immunother 2010;59:1601-1606.
14. Proulx DR, Ruslander DM, Dodge RK, et al. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Vet Radiol Ultrasound 2003;44:352-359.
15. Bostock DE. Prognosis after surgical excision of canine melanomas. Vet Pathol 1979;16:32-40.
16. Bonin S, Hlubek F, Benhattar J, et al. Multicentre validation study of nucleic acids extraction from FFPE tissues. Virchows Arch 2010;457:309-317.
17. Farragher SM, Tanney A, Kennedy RD, et al. RNA expression analysis from formalin fixed paraffin embedded tissues. Histochem Cell Biol 2008;130:435-445.
18. Lee SY, Jeoung D. The reverse proteomics for identification of tumor antigens. J Microbiol Biotechnol 2007;17:879-890.
19. Jager D, Taverna C, Zippelius A, et al. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer Immunol Immunother 2004;53:144-147.
20. Jaanson N, Moll K, Kulla A, et al. Identification of the immunodominant regions of the melanoma antigen tyrosinase by antityrosinase monoclonal antibodies. Melanoma Res 2003;13:473-482.
21. Chen YT, Stockert E, Tsang S, et al. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci U S A 1995;92:8125-8129.
22. Willers J, Lucchese A, Mittelman A, et al. Definition of antityrosinase MAb T311 linear determinant by proteome-based similarity analysis. Exp Dermatol 2005;14:543-550.
23. Cangul IT, van Garderen E, van der Poel HJ, et al. Tyrosinase gene expression in clear cell sarcoma indicates a melanocytic origin: insight from the first reported canine case. APMIS 1999;107:982-988.
24. Catchpole B, Gould SM, Kellett-Gregory LM, et al. Development of a multiple-marker polymerase chain reaction assay for detection of metastatic melanoma in lymph node aspirates of dogs. Am J Vet Res 2003;64:544-549.
25. Oetting WS. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): a model for understanding the molecular biology of melanin formation. Pigment Cell Res 2000;13:320-325.
26. Gradilone A, Cigna E, Agliano A, et al. Tyrosinase expression as a molecular marker for investigating the presence of circulating tumor cells in melanoma patients. Curr Cancer Drug Targets 2010;10:529-538.
27. Quaglino P, Osella-Abate S, Cappello N, et al. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. Melanoma Res 2007;17:75-82.
28. Gkalpakiotis S, Arenberger P, Kremen J, et al. Quantitative detection of melanoma-associated antigens by multimarker realtime RT-PCR for molecular staging: results of a 5 years study. Exp Dermatol 2010;19:994-999.
29. Arenberger P, Arenbergerova M, Vohradnikova O, et al. Early detection of melanoma progression by quantitative real-time RT-PCR analysis for multiple melanoma markers. Keio J Med 2008;57:57-64.